Ecallantide is administered by a healthcare professional in a controlled medical environment.

• Route of Administration: It is given as a subcutaneous injection, typically into the abdomen, thigh, or upper arm.
• Dosage and Frequency: The standard dose is 30 mg, which is administered as three separate 10 mg injections. If the HAE attack persists, an additional 30 mg dose may be administered within a 24-hour period.
• Monitoring: Patients are typically monitored for at least an hour after the injection due to the risk of hypersensitivity reactions.

5. Advantages

• Targeted Treatment: Ecallantide provides a targeted approach to treating HAE attacks by directly inhibiting the protein (plasma kallikrein) that drives the production of bradykinin.
• Effective Symptom Relief: Clinical trials have shown that Ecallantide significantly reduces the severity and duration of acute HAE attacks.
• Quick Onset of Action: Its mechanism allows for a rapid reduction in swelling and other symptoms.

Ecallantide is a potent and selective inhibitor of a protein called plasma kallikrein.

• Kallikrein-Kinin System: Hereditary angioedema is caused by a deficiency or dysfunction of C1-inhibitor, a protein that regulates the kallikrein-kinin system. Without proper regulation, an overabundance of plasma kallikrein is produced.
• Bradykinin Production: Plasma kallikrein is responsible for cleaving a protein called high-molecular-weight kininogen to produce bradykinin.
• Mechanism of Action: Ecallantide works by binding to and inhibiting plasma kallikrein, thereby stopping the production of excess bradykinin. Since bradykinin is a key mediator of the swelling and pain in HAE, this action helps to reduce the symptoms of an acute attack.

3. Interaction with Other Medicine

According to available information, there are no known drug-drug interactions with Ecallantide. However, as with any medication, it is essential to inform your healthcare provider of all prescription and non-prescription drugs, vitamins, and herbal supplements you are taking.

Side effects from Ecallantide can range from common to severe.

• Common Side Effects: Headache, nausea, diarrhea, fatigue, injection site reactions (pain, redness), upper respiratory tract infections, and fever.
• Serious Side Effects:
  • Anaphylaxis: This is the most serious and life-threatening side effect. Anaphylaxis has been reported in a small percentage of patients (around 4%) and can occur within one hour of administration. Symptoms can include hives, rash, swelling of the face, tongue, or throat, dizziness, shortness of breath, and a drop in blood pressure. Due to this risk, the drug carries a black box warning.
  • Hypersensitivity Reactions: Other hypersensitivity reactions can occur, with symptoms that may mimic HAE attacks. Patients are closely monitored for this reason.

• Anaphylaxis: A black box warning highlights the risk of anaphylaxis. The drug should only be administered in a medical setting by a healthcare professional with the ability to manage anaphylaxis. Patients with a known hypersensitivity to Ecallantide should not use this medication.
• Not for Self-Administration: Due to the risk of anaphylaxis, Ecallantide is not for self-administration.
• Not for ACE Inhibitor-Induced Angioedema: Ecallantide is not indicated for treating angioedema caused by ACE inhibitors, as the mechanism is different.
• Pregnancy and Breastfeeding: The risks to an unborn baby or a breastfed infant are not fully known. Patients who are pregnant, planning to become pregnant, or breastfeeding should discuss the risks and benefits with their doctor.

According to available information, there are no known drug-drug interactions with Ecallantide. However, as with any medication, it is essential to inform your healthcare provider of all prescription and non-prescription drugs, vitamins, and herbal supplements you are taking.

• Adults and Adolescents (≥12 years): The recommended dose is 30 mg administered as three 10 mg subcutaneous injections.
• Dose Repetition: If the attack has not resolved, an additional 30 mg may be given within 24 hours.

Ecallantide is a prescription-only medication. It is not available over the counter. A doctor must diagnose the condition as hereditary angioedema, and the medication must be administered in a controlled clinical environment with emergency medical support available.

1. What is Ecallantide?
   Ecallantide is a medication used to treat acute attacks of hereditary angioedema (HAE).

2. How does Ecallantide work?
   It works by inhibiting plasma kallikrein, an enzyme involved in the swelling process of HAE.

3. What condition does Ecallantide treat?
   It is used for the treatment of acute attacks of hereditary angioedema in patients aged 12 years and older.

4. How is Ecallantide administered?
   It is given as a subcutaneous injection by a healthcare professional.

5. Can Ecallantide be used for prevention of HAE attacks?
   No, it is only indicated for acute attacks, not for long-term prevention.

6. How quickly does Ecallantide start working?
   Relief from symptoms usually begins within a few hours of administration.

7. Is Ecallantide safe for children?
   It is approved for use in patients 12 years and older.

8. What are the common side effects of Ecallantide?
   Headache, nausea, fever, diarrhea, and injection site reactions.

9. Can Ecallantide cause serious side effects?
   Yes, severe allergic reactions (anaphylaxis) may occur in some patients.

10. Who should not take Ecallantide?
    Patients with a history of hypersensitivity to Ecallantide should avoid it.

11. Can patients self-inject Ecallantide?
    No, it must be administered by a healthcare professional due to the risk of anaphylaxis.

12. How is Ecallantide supplied?
    It comes as a single-use vial for subcutaneous injection.

13. Is Ecallantide used for conditions other than HAE?
    Currently, it is only FDA-approved for hereditary angioedema.

14. Can Ecallantide be used during pregnancy?
    There is limited data, so it should be used only if clearly needed under medical supervision.

15. Is Ecallantide effective for all HAE patients?
    It is effective for many, but not all patients respond the same way.

16. Does Ecallantide interact with other medications?
    No major drug interactions are well-documented, but always consult a doctor.

17. How often can Ecallantide be given?
    It is usually given at the time of an acute HAE attack; additional doses may be considered if symptoms persist.

18. What monitoring is required with Ecallantide?
    Patients should be monitored for signs of anaphylaxis during and after injection.

19. Is Ecallantide a long-term cure for HAE?
    No, it only treats acute episodes and does not cure the condition.

20. Where can patients access Ecallantide?
    It is available by prescription and typically administered in a clinic or hospital setting.